Product Information
LEVONORGESTREL 1.5 MG TABLET is a generic product labeled by Rugby Laboratories, priced at $6.3305 per EA under NDC 00536143363. Its NADAC has been published 76 times since Apr 23, 2025.
FDA first approved this application on Dec 8, 2015.
Strength
1.5 mg/1
Manufacturer
Rugby LaboratoriesNDC
00536143363
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVONORGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA206867FDA Approved
12/8/2015
On Market Since
5/24/2024
Pharmacological Classes
Price Statistics
The NADAC for LEVONORGESTREL 1.5 MG TABLET has been published 76 times since Apr 23, 2025, and over the history we have for it it has declined 3.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3305 per EA |
|---|---|
| All-time high | $6.8109 (Feb 11, 2026) |
| All-time low | $6.2162 (Oct 22, 2025) |
| 52-week high | $6.8109 |
| 52-week low | $6.2162 |
| Median price | $6.4454 |
| Average price | $6.4615 |
| Largest weekly change | +3.6% (Dec 17, 2025) |
| Weeks tracked | 76 |
| Tracking since | Apr 23, 2025 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVONORGESTREL 1.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVONORGESTREL 1.5 MG TABLET, manufactured by Rugby Laboratories, is $6.3305 per EA (NDC 00536143363), effective Sep 30, 2026.
How has the price of LEVONORGESTREL 1.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVONORGESTREL 1.5 MG TABLET has declined 3.2%. It has been tracked across 76 weekly CMS publications since Apr 23, 2025.
What are the highest and lowest recorded NADAC prices for LEVONORGESTREL 1.5 MG TABLET?
Since Apr 23, 2025, the NADAC for LEVONORGESTREL 1.5 MG TABLET has ranged from a low of $6.2162 (Oct 22, 2025) to a high of $6.8109 (Feb 11, 2026), with a median of $6.4454 per EA.
Are there cheaper alternatives to LEVONORGESTREL 1.5 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LEVONORGESTREL 1.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LEVONORGESTREL 1.5 MG TABLET?
LEVONORGESTREL 1.5 MG TABLET (NDC 00536143363) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.